In contrast, transgenic mice (APP/PS1) lacking ApoA1 showed increased amyloid deposition and astrogliosis in the cerebral cortex, as well as the development of cerebral amyloid angiopathy [63]. The gene discussed is APOA1; the disease is cerebral amyloid angiopathy.